Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Shares Outstanding (2018 - 2025)

AVITA Medical filings provide 8 years of Shares Outstanding readings, the most recent being $30.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 16.0% to $30.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $30.6 million, a 16.0% increase, with the full-year FY2025 number at $30.6 million, up 16.0% from a year prior.
  • Shares Outstanding hit $30.6 million in Q4 2025 for AVITA Medical, roughly flat from $30.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $30.6 million in Q4 2025 to a low of $24.8 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $25.5 million (2023), compared with a mean of $26.0 million.
  • Biggest five-year swings in Shares Outstanding: rose 16.5% in 2021 and later grew 0.42% in 2022.
  • AVITA Medical's Shares Outstanding stood at $24.9 million in 2021, then increased by 1.13% to $25.2 million in 2022, then rose by 1.88% to $25.7 million in 2023, then increased by 2.62% to $26.4 million in 2024, then grew by 16.0% to $30.6 million in 2025.
  • The last three reported values for Shares Outstanding were $30.6 million (Q4 2025), $30.5 million (Q3 2025), and $26.6 million (Q2 2025) per Business Quant data.